Accumulating evidence suggests a key role for AMPK in cancer initiation, by exerting tumor-suppressor functions, influencing inflammation, cell survival, and modulating cell-cycle arrest, and blocking the metabolic changes that take place during tumorigenesis [23,24,25,26,27]. The gene discussed is PRKAA1; the disease is neoplasm.